Literature DB >> 866573

Idiopathic membranous nephropathy.

A M Pierides, P Malasit, A R Morley, R Willkinson, P R Uldall, D N Kerr.   

Abstract

The clinical and histopathological features of 37 patients with idiopathic membranous nephropathy are presented. Males were four times as commonly affected as females and the age at presentation ranged from nine to 70 years. The period of observation varied from three months to 23 years. Twenty-eight patients (76 percent) presented with the nephrotic syndrome and nine patients (24 per cent) presented with non-nephrotic proteinuria. At the end of the study, of the patients presenting with the nephrotic syndrome, seven (25 per cent) were in remission, seven (25 per cent) remained nephrotic, nine (32 per cent) showed only proteinuria and five (18 per cent) were dead or on dialysis. Altogether eight patients (28 per cent) developed renal failure. The nine patients who presented with non-nephrotic proteinuria appeared to do better, and none developed renal failure. The occurrence of spontaneous remission makes assessment of benefit from immunosuppressive therapy difficult. However, analysis of our data and a review of the literature suggest that in this condition oral prednisone, cyclophosphamide and azathioprine have no significant therapeutic properties. Histological assessment confirmed the occurrence of mild (Grade 1) changes in patients biopsied soon after presentation, and tubular atrophy increased with the duration of illness. Immunofluorescence confirmed deposition of mainly IgG and complement. Repeat biopsies in 14 patients showed no histological improvement and remission was not accompanied by resolution of histological abnormalities.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 866573

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  9 in total

1.  Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study).

Authors:  G Mohácsi; A Magori; S Sonkodi
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 2.  Therapy of idiopathic membranous nephropathy.

Authors:  C Ponticelli; P Zucchelli; P Passerini
Journal:  Springer Semin Immunopathol       Date:  1987

3.  Membranous nephropathy: high-dose alternate-day therapy with prednisone.

Authors:  J Hopper; C G Biava; W H Tu
Journal:  West J Med       Date:  1981-07

4.  Idiopathic membranous glomerulonephritis: aspects of geographical differences.

Authors:  S Abe; Y Amagasaki; K Konishi; E Kato; S Iyori; H Sakaguchi
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

5.  Low-dose prednisolone/chlorambucil therapy in patients with severe membranous glomerulonephritis.

Authors:  R Brunkhorst; E Wrenger; K M Koch
Journal:  Clin Investig       Date:  1994-03

6.  Factors contributing to the outcome in 100 adult patients with idiopathic membranous glomerulonephritis.

Authors:  T Tóth; S Takebayashi
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

7.  Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis.

Authors:  M Schulze; C J Pruchno; M Burns; P J Baker; R J Johnson; W G Couser
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

Review 8.  Genetics of membranous nephropathy.

Authors:  Sanjana Gupta; Anna Köttgen; Elion Hoxha; Paul Brenchley; Detlef Bockenhauer; Horia C Stanescu; Robert Kleta
Journal:  Nephrol Dial Transplant       Date:  2018-09-01       Impact factor: 5.992

Review 9.  Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia.

Authors:  Francesco Scolari; Federico Alberici; Federica Mescia; Elisa Delbarba; Hernando Trujillo; Manuel Praga; Claudio Ponticelli
Journal:  Front Immunol       Date:  2022-03-01       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.